Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Aylward

Showing results (1-10 of 54) with videos related to

Pageof 6
Sort By:
BMJ (Clinical Research Ed.)|October 5, 1996
Government's expert group has reached consensus on prognosis of chronic fatigue syndromeM Aylward
Postgraduate Medical Journal|January 1, 1978
Coagulation factors in opposed and unopposed oestrogen treatment at the climactericM Aylward
Rheumatology and Rehabilitation|August 1, 1976
Is alclofenac specific?M Aylward
British Medical Journal|August 11, 1973
Toxicity of benorylateM Aylward
British Medical Journal|April 14, 1973
Toxicity of benorylateM Aylward
Current Medical Research and Opinion|January 1, 1975
A review of possible mechanisms of action of the antirheumatic drug, alclofenacM Aylward
The Journal of International Medical Research|January 1, 1979
Hexopal in Raynaud's diseaseM Aylward
The British Journal of Clinical Practice|July 1, 1973
Alclofenac in rheumatoid arthritis: an evaluation of its anti-inflammatory and analgesic effectsM Aylward
BMJ (Clinical Research Ed.)|January 28, 1995
Certifying incapacity for workM Aylward
BMJ (Clinical Research Ed.)|April 19, 1997
Benefits Agency always holds consent before approaching healthcare professionals for informationM Aylward
Pageof 6

Showing results (1-10 of 54) with videos related to

Sort By:
Pageof 6
BMJ (Clinical Research Ed.)|October 5, 1996
Government's expert group has reached consensus on prognosis of chronic fatigue syndromeM Aylward
Postgraduate Medical Journal|January 1, 1978
Coagulation factors in opposed and unopposed oestrogen treatment at the climactericM Aylward
Rheumatology and Rehabilitation|August 1, 1976
Is alclofenac specific?M Aylward
British Medical Journal|August 11, 1973
Toxicity of benorylateM Aylward
British Medical Journal|April 14, 1973
Toxicity of benorylateM Aylward
Current Medical Research and Opinion|January 1, 1975
A review of possible mechanisms of action of the antirheumatic drug, alclofenacM Aylward
The Journal of International Medical Research|January 1, 1979
Hexopal in Raynaud's diseaseM Aylward
The British Journal of Clinical Practice|July 1, 1973
Alclofenac in rheumatoid arthritis: an evaluation of its anti-inflammatory and analgesic effectsM Aylward
BMJ (Clinical Research Ed.)|January 28, 1995
Certifying incapacity for workM Aylward
BMJ (Clinical Research Ed.)|April 19, 1997
Benefits Agency always holds consent before approaching healthcare professionals for informationM Aylward
Pageof 6